Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2037

Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.

Patents
1,615

Quick answer

1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9650607

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9650447

    Complement receptor 2 (CR2) targeting groups

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9650444

    Anti-PDGFR-beta antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9650422

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9650403

    Platinum (II) compound, preparation method therefor, and pharmaceutical composition and application thereof

    China State Institute of Pharmaceutical Industry · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9650407

    Reprogramming of cellular adhesion

    The Regents of the University of California · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9650352

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9650365

    Itraconazole analogues and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9650342

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9649344

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9649358

    Methods for use of neural stem cell compositions for treatment of central nervous system lesions

    The Regents of the University of California · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9649339

    LAT adapter molecule for enhanced T-cell signaling and method of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9649373

    Neoseptins: small molecule adjuvants

    The Board of Regents of the University of Texas System · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9649340

    Methods for producing enriched populations of human retinal pigment epithelium cells

    Astellas Institute for Regenerative Medicine · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9649327

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9649321

    Phosphonate compounds

    The Regents of the University of California · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9649284

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9648899

    Drinking water formulation and method and article relating to same

    ESSENTIALIFE HOMEOPATHICS · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 2017136004

    Opioid Agonist Antagonist Combinations

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu May 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9657012

    FAAH inhibitors

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9657090

    Method of treating alveolar bone loss through the use of anti-sclerostin antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9656001

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9657096

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9655909

    Personalized medicine for the prediction of therapy targeting the hedgehog pathway

    The Board of Regents of the University of Texas System · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9657269

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9657292

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9656993

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9658230

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Ludwig-Maximilians-Universitat Munchen · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9655881

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9657288

    Connector compound peptide phage display

    BICYCLE THERAPEUTICS LIMITED · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9657270

    Human disc tissue

    DiscGenics, Inc. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9657267

    Ex host maturation of germline stem cells

    PrimeGen Biotech LLC · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9655366

    Volatile blends and the effects thereof on the navel orangeworm moth

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9657102

    Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9657099

    Anti-glucagon antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9657066

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9657023

    Polymorph of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9657007

    Substituted aminopyrimidine compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9656999

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9657004

    Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9655352

    Humanized M-CSF mice

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9655917

    Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

    Northwestern University · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9655969

    Inhalable medicament comprising tiotropium

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9655938

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9655900

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9655842

    Injectable non-aqueous compositions and methods of treating vascular disease

    Covidien LP · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. EP 3169322

    DIÄTETISCHE ZUSAMMENSETZUNG MIT ANTIDYSLIPIDÄMISCHER AKTIVITÄT

    BERLIN-CHEMIE AG [DE] · Granted Wed May 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9663504

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2037?

1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.